Identifying and characterizing binding sites on the irreversible inhibition of human glutathione S-transferase P1-1 by S-thiocarbamoylation. 2012

Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
Área de Química Física, Universidad de Almería, Crta. de Sacramento s/n, 04120 Almería, Spain.

Human glutathione S-transferase P1-1 (hGST P1-1) is involved in cell detoxification processes through the conjugation of its natural substrate, reduced glutathione (GSH), with xenobiotics. GSTs are known to be overexpressed in tumors, and naturally occurring isothiocyanates, such as benzyl isothiocyanate (BITC), are effective cancer chemopreventive compounds. To identify and characterize the potential inhibitory mechanisms of GST P1-1 induced by isothiocyanate conjugates, we studied the binding of GST P1-1 and some cysteine mutants to the BITC-SG conjugate as well as to the synthetic S-(N-benzylcarbamoylmethyl)glutathione conjugate (BC-SG). We report here the inactivation of GST P1-1 through the covalent modification of two Cys47 residues per dimer and one Cys101. The evidence has been compiled by isothermal titration calorimetry (ITC) and electrospray ionization mass spectrometry (ESI-MS). ITC experiments suggest that the BITC-SG conjugate generates adducts with Cys47 and Cys101 at physiological temperatures through a corresponding kinetic process, in which the BITC moiety is covalently bound to these enzyme cysteines through an S-thiocarbamoylation reaction. ESI-MS analysis of the BITC-SG incubated enzymes indicates that although the Cys47 in each subunit is covalently attached to the BITC ligand moiety, only one of the Cys101 residues in the dimer is so attached. A plausible mechanism is given for the emergence of inactivation through the kinetic processes with both cysteines. Likewise, our molecular docking simulations suggest that steric hindrance is the reason why only one Cys101 per dimer is covalently modified by BITC-SG. No covalent inactivation of GST P1-1 with the BC-SG inhibitor has been observed. The affinities and inhibitory potencies for both conjugates are high and very similar, but slightly lower for BC-SG. Thus, we conclude that the presence of the sulfur atom from the isothiocyanate moiety in BITC-SG is crucial for its irreversible inhibition of GST P1-1.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002151 Calorimetry The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
May 2003, Chemico-biological interactions,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
July 2001, Biochimica et biophysica acta,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
August 2002, IUBMB life,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
October 2003, Biochemical pharmacology,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
August 2000, Chemico-biological interactions,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
April 1994, Biochemistry and molecular biology international,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
December 2013, Biochemistry,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
June 1991, Biochemical pharmacology,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
December 2021, Investigational new drugs,
Indalecio Quesada-Soriano, and Alessandra Primavera, and Juan M Casas-Solvas, and Ramiro Téllez-Sanz, and Carmen Barón, and Antonio Vargas-Berenguel, and Mario Lo Bello, and Luís García-Fuentes
May 1994, The Journal of biological chemistry,
Copied contents to your clipboard!